|
ZNF326 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.782300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.333540E-02 |
| Normal-vs-Stage2 |
3.488000E-01 |
| Normal-vs-Stage3 |
7.197600E-03 |
| Normal-vs-Stage4 |
7.072500E-02 |
| Stage1-vs-Stage2 |
6.920000E-01 |
| Stage1-vs-Stage3 |
3.881800E-01 |
| Stage1-vs-Stage4 |
6.368800E-01 |
| Stage2-vs-Stage3 |
4.110400E-01 |
| Stage2-vs-Stage4 |
5.889000E-01 |
| Stage3-vs-Stage4 |
9.449800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.495600E-02 |
| Normal-vs-AfricanAmerican |
8.857800E-02 |
| Normal-vs-Asian |
5.893600E-01 |
| Caucasian-vs-AfricanAmerican |
8.455600E-01 |
| Caucasian-vs-Asian |
6.133000E-01 |
| AfricanAmerican-vs-Asian |
6.841800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.307680E-02 |
| Normal-vs-Female |
3.527200E-01 |
| Male-vs-Female |
5.965700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.998300E-02 |
| Normal-vs-Extreme_Weight |
3.280900E-03 |
| Normal-vs-Obese |
1.793210E-01 |
| Normal-vs-Extreme_Obese |
9.362300E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.275200E-01 |
| Normal_Weight-vs-Obese |
5.853800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.417400E-01 |
| Extreme_Weight-vs-Obese |
7.945900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.366200E-01 |
| Obese-vs-Extreme_Obese |
5.043200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.002600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.248200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.880200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.061550E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.556200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.066300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.660300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.051660E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.630500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.667770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.183410E-01 |
| Normal-VS-Type2 PRCC |
7.81499999999991E-05 |
| Normal-VS-KIRP CIMP |
4.061800E-02 |
| Normal-VS-Unclassified PRCC |
5.711800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.643200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.729800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.921600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.901800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.692180E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.997200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.69470000000494E-05 |
| Normal-vs-N1 |
2.276800E-01 |
| Normal-vs-N2 |
1.786230E-02 |
| N0-vs-N1 |
6.863700E-02 |
| N0-vs-N2 |
2.965000E-01 |
| N1-vs-N2 |
1.311650E-01 |
|
|
